Gemcitabine elaidate

ArtNr	V4887-250mg
Hersteller	InvivoChem LLC
CAS-Nr.	210829-30-4
Menge	250 mg
Quantity options	100 mg 25 mg 500 mg 50 mg
Kategorie	Reagents & Chemicals Molecules
Typ	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Lieferbar
Description	InvivoChem Cat #:V4887CAS #:210829-30-4Purity >=98% Description: Gemcitabine elaidate (formerly know as CP-4126 and CO-101) is a potent, lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), which is an antimetabolite deoxynucleoside analogue with potential antineoplastic activity. Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. Description: Gemcitabine elaidate (formerly know as CP-4126 and CO-101) is a potent, lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), which is an antimetabolite deoxynucleoside analogue with potential antineoplastic activity. Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.Description References: J Clin Oncol. 2013 Dec 10; 31(35):4453-61. References: J Clin Oncol. 2013 Dec 10; 31(35):4453-61. References: J Clin Oncol. 2013 Dec 10; 31(35):4453-61. References CAS : 95058-81-4 (free base); 122111-03-9 (HCl); 116371-67-6 (Gemcitabine monophosphate free acid); 1638288-31-9 (Gemcitabine monophosphate disodium salt); 840506-29-8 Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine; 892128-60-8 (LY2334737, an orally bioavailable prodrug of gemcitabine) CAS : 95058-81-4 (free base); 122111-03-9 (HCl); 116371-67-6 (Gemcitabine monophosphate free acid); 1638288-31-9 (Gemcitabine monophosphate disodium salt); 840506-29-8 Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine; 892128-60-8 (LY2334737, an orally bioavailable prodrug of gemcitabine)CAS : 95058-81-4 (free base); 122111-03-9 (HCl); 116371-67-6 (Gemcitabine monophosphate free acid); 1638288-31-9 (Gemcitabine monophosphate disodium salt); 840506-29-8 Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine; 892128-60-8 (LY2334737, an orally bioavailable prodrug of gemcitabine)
	Name: Gemcitabine elaidate CAS#: 210829-30-4 Chemical Formula: C27H43F2N3O5 Exact Mass: 527.31708 Molecular Weight: 527.644 Elemental Analysis: C, 61.46; H, 8.21; F, 7.20; N, 7.96; O, 15.16
Storage	-20C for 3 years in powder form
	-80C for 2 years in solvent
Technical Information	8

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 250 mg

lieferbar

Lieferung vsl. bis 02.10.2025

Express-Lieferung: 16 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern